Clinical Trials on Bacterial Signature

Total 17710 results

National Health Research Institutes, Taiwan
Tri-Service General Hospital; Academia Sinica, Taiwan; Fu Jen Catholic University

Completed

Vegetable Signature From Human Metabolomics Responses

Vegetable Signature Documentation With Metabolomic Technique
Centre Georges Francois Leclerc

Completed

Validation of a Genetic Signature to Predict the Development of Sarcomas (PREDISARC)

Genetic Signature in Development of Sarcomas

France
Assistance Publique - Hôpitaux de Paris

Unknown

Microbiotic Analysis in Digestive Endocrine Tumors (MicroTEND)

Fecal Microbiota | Digestive Neuroendocrine Tumor | Bacterial Signature
The Fourth Affiliated Hospital of Anhui Medical...

Completed

Precise Gene Signature for Predicting Outcomes in PDAC

Stage I-II Pancreatic Ductal Adenocarcinoma (PDAC) | Precise Prognostic and Predictive Signature

China
Assiut University

Unknown

Haemorrhoidectomy by Ligasure and Conventional Surgery

Ligature; Hemorrhage
Seoul National University Hospital

Completed

Clinical Usefulness of Therapeutic Drug Monitoring of Colistin in Patients Treated With Colistin.

Multidrug-resistant Gram-negative Bacteria Infection

Korea, Republic of
Singapore General Hospital
National Medical Research Council (NMRC), Singapore

Recruiting

Evaluating a Novel Individualised Treatment Strategy for Carbapenem-Resistant Gram-Negative Bacteria Infections

Antibiotic Therapy

Singapore
Ministry of Health, Rwanda

Unknown

A Trial Assessing Efficacy of Various Antimicrobial Techniques for Reducing Bacterial Load (RMC-11)

Disease Due to Gram-positive Bacteria

Rwanda
Nanjing First Hospital, Nanjing Medical University

Recruiting

Fucoidan Assisted Eradication of Helicobacter Pylori

Helicobacter Pylori Infection | Intestinal Bacteria Flora Disturbance

China
University of Maryland, Baltimore

Terminated

Targeted Gown and Glove Intervention in Nursing Homes (TAGG)

Staphylococcus Aureus | Carbapenem Resistant Gram Negative Bacteria

United States
G. d'Annunzio University

Unknown

0.2% Chx Gel vs Implant Bacterial Contamination

Bone Resorption | Bacteria Caused Disease

Italy
Johann DD Pitout
Merck Sharp & Dohme LLC

Completed

International Travel and the Spread of Extended-spectrum Beta-lactamase-producing Escherichia Coli

Infection Due to Resistant Bacteria

Canada
University of Santiago de Compostela

Completed

Microbial Growth in the Suture Thread, After Application of Different Antiseptic Gels in Mandibular Third Molars Extraction

Bacterial Growth | Oral Surgery | Wisdom Teeth | Third Molar Surgery | Bioadhesive Gel | Suture Bacteria | Antiseptic Gel | Chistosan | Clorhexidine Gel Bacteria | Clorhexidine-chitosan
University Hospital, Basel, Switzerland
Stiftung Forschung Infektionskrankheiten, Basel, Switzerland

Completed

Simplified GBS Screening and Prevalence of ESBL in Pregnant Women

Group B Streptococcal Infection | Infection Due to ESBL Bacteria

Switzerland
University of Geneva, Switzerland
Centre Hospitalier Universitaire Vaudois; Cantonal Hospital of St. Gallen

Completed

Antibiotic Durations for Gram-negative Bacteremia (PIRATE)

Bacteraemia Caused by Gram-Negative Bacteria

Switzerland
The University of Queensland
Merck Sharp & Dohme LLC

Withdrawn

Ceftolozane-tazobactam Versus Meropenem for ESBL and AmpC-producing Enterobacterales Bloodstream Infection (MERINO III)

Bacteremia Caused by Gram-Negative Bacteria

Spain, Australia, Singapore, Italy, Saudi Arabia
MJM Bonten
Paris 12 Val de Marne University

Completed

Ecological Effects of Decolonisation Strategies in Intensive Care (RGNOSIS)

ICU-ecology (Multidrug Resistant Bacteria) | ICU-acquired Bacteraemia

Belgium, Spain, United Kingdom, Italy, Portugal, Slovenia
University Hospital of Cologne
Charite University, Berlin, Germany; University Hospital Tuebingen; University... and other collaborators

Completed

Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives (ABSOLUTE)

Clostridium Difficile Infection | Nosocomial Infection | VRE Infection | MRGN Bacteria

Germany
Connie Price
United States Department of Defense; Accelerate Diagnostics, Inc.

Completed

Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections (RAMPED)

Infection | Skin and Subcutaneous Tissue Bacterial Infections | Healthcare-associated Infection | Infection Due to Resistant Bacteria

United States
Denver Health and Hospital Authority
United States Department of Defense; Accelerate Diagnostics, Inc.

Completed

Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections

Skin and Subcutaneous Tissue Bacterial Infections | Healthcare-associated Infection | INFECTIONS | Infection Due to Resistant Bacteria

United States
University of Michigan
Wayne State University; Henry Ford Health System; Agency for Healthcare Research... and other collaborators

Completed

Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection

Clostridium Difficile Infection | Healthcare Associated Infection | Infection Due to Multidrug Resistant Bacteria

United States
Gamaleya Research Institute of Epidemiology and...

Not yet recruiting

Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV

Gram-Negative Bacterial Infections | Bacteremia Caused by Gram-Negative Bacteria | Gram Negative Pneumonia
The Methodist Hospital Research Institute
M.D. Anderson Cancer Center; National Institute of Allergy and Infectious Diseases... and other collaborators

Recruiting

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)

Antibiotic Resistant Infection | Clostridium Difficile | Antimicrobial Drug Resistance | Carbapenem-Resistant Enterobacteriaceae Infection | Vancomycin Resistant Enterococci Infection | Vancomycin-Resistant Enterococcal Infection | Carbapenem Resistant Bacterial Infection | Extended Spectrum Beta-Lactamase...

United States
Danish Head and Neck Cancer Group

Recruiting

DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC. (DAHANCA30)

Hypoxia | Head and Neck Squamous Cell Carcinoma | Radiotherapy | Hypoxic Modification | Gene Profile, Gene Signature

Denmark
Academisch Medisch Centrum - Universiteit van Amsterdam...
Centers for Disease Control and Prevention; Wageningen University and Research

Completed

The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses (Rota-biome)

Tetanus | Rotavirus Infections | Reaction - Vaccine Nos | Intestinal Bacteria Flora Disturbance | Streptococcal Pneumonia

Netherlands
University of Alabama at Birmingham

Terminated

Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates

Respiratory Tract Infections | Bacteria Infection

United States
the Jeunes en Neuroradiologie Interventionnelle...
University Hospital, Limoges; Sainte Anne Hospital (Paris)

Not yet recruiting

Neurological Complication of Infective Endocarditis: A Prospective Multi-site Cohort Study

Endocarditis, Bacterial | Aneurysm, Intracranial Mycotic
Hellenic Institute for the Study of Sepsis
European Commission

Completed

Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System (INCLASS)

Pneumonia | Sepsis | Mortality | Biomarkers | Respiratory Distress Syndrome | Multiple Organ Failure | Gram-Negative Bacteria Infection

Greece, Belgium
Hôpital Louis Mourier

Completed

Microbial and Pharmacological Assessment of Chlorhexidine

Pneumonia, Ventilator-Associated | Infection, Bacterial | Chlorhexidine | Oropharynx Abnormality | Bacterium; Agent
GlaxoSmithKline

Completed

Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects

Infections, Bacterial

United States
GlaxoSmithKline

Terminated

A Three-part Study to Determine the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Volunteers and Healthy Male Japanese Subjects

Infections, Bacterial

United States
GlaxoSmithKline

Completed

Amoxicillin Bioequivalence Study Brazil - Fast

Infections, Bacterial

Brazil
GlaxoSmithKline

Withdrawn

A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women

Infections, Bacterial
Sir Run Run Shaw Hospital
University of Birmingham

Unknown

Gram-negative Bacilli and MRSA Screening in ICU in China

Infections, Bacterial

China
GlaxoSmithKline

Completed

Relative Bioavailability, Safety, Tolerability, Pharmacokinetics (PK) and Food Effect Study of GSK2140944 in Healthy Subjects

Infections, Bacterial

United States
GlaxoSmithKline

Completed

A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects

Infections, Bacterial

Australia
GlaxoSmithKline

Completed

Single Dose Escalation First Time in Human PK Study

Infections, Bacterial

Australia
GlaxoSmithKline

Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects

Infections, Bacterial

United States
GlaxoSmithKline

Completed

To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944

Infections, Bacterial

United States
GlaxoSmithKline

Completed

A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy Subjects

Infections, Bacterial

United States
GlaxoSmithKline

Completed

Retapamulin Ointment in Healthy Adults Nasally Colonized With Staphylococcus Aureus

Infections, Bacterial

United States
GlaxoSmithKline

Withdrawn

A Single Center Four Part Study in Healthy Adult Subjects to Evaluate: the Safety, Tolerability and Pharmacokinetics of a Single Oral Dose and Repeat Escalating Oral Doses of GSK945237; the Effect of Linezolid on Hematology Safety Parameters; and the Effects of GSK945237 and Moxifloxacin on QTc.

Infections, Bacterial
GlaxoSmithKline

Withdrawn

A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers

Infections, Bacterial
King Faisal University

Suspended

In Vitro Activity of Tigecycline Among Key Bacterial Pathogens Exhibiting Multidrug Resistance

Infections, Bacterial

Saudi Arabia
Laboratoires Thea

Completed

Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.

Purulent Bacterial Conjunctivitis

France
GlaxoSmithKline

Completed

Drug-drug Interaction Study of Gepotidacin

Infections, Bacterial

United States
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Completed

Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function

Infections, Bacterial

United States
GlaxoSmithKline

Terminated

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Intravenous Single Dose and Repeat Dose of GSK3342830

Infections, Bacterial

Australia
GlaxoSmithKline

Completed

Relative Bioavailability Study in Healthy Subjects (PDF112034)

Infections, Bacterial

United States
GlaxoSmithKline

Completed

A Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK1322322 in Healthy Subjects

Infections, Bacterial

Australia

Clinical Trials on Bacterial Signature

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations